Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_assertion wasGeneratedBy ECO_0000203 NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_assertion wasDerivedFrom befree-20150227 NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_assertion SIO_000772 16849682 NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_assertion evidence source_evidence_literature NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.
- NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_assertion description "[A quantitative fluorogenic real-time polymerase chain reaction (PCR) assay was used to examine primary tumor DNA and urine sediment DNA from 15 patients with bladder cancer and 25 control subjects for promoter hypermethylation of nine genes (APC, ARF, CDH1, GSTP1, MGMT, CDKN2A, RARbeta2, RASSF1A, and TIMP3) to identify potential biomarkers for bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861646.RAORYvZLbqnGgY1sO4P1-7F449niv9nwJiUs8f_r9P3_s130_provenance.